Regulatory PathRegulatory requirements compared

Active substances

Amlodipine + Perindopril

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
COVERAM 10MG-10MG TABLETS10,10 mg,mgTablet · Oral use30 BottleSAR 117.20Generic · PrescriptionSERVIERValid
COVERAM 10MG-5MG TABLETS5,10 mg,mgTablet · Oral use30 BottleSAR 102.70Generic · PrescriptionSERVIERValid
COVERAM 5MG-10MG TABLETS10,5 mg,mgTablet · Oral use30 BottleSAR 82.90Generic · PrescriptionSERVIERValid
COVERAM 5MG-5MG TABLETS5,5 mg,mgTablet · Oral use30 BottleSAR 68.45Generic · PrescriptionSERVIERValid
PROVINDA PLUS10,10 mg,mgTablet · Oral use30 BlisterSAR 85.90Generic · PrescriptionSPIMACOValid
PROVINDA PLUS10,5 mg,mgTablet · Oral use30 BlisterSAR 75.35Generic · PrescriptionSPIMACOValid
PROVINDA PLUS5,10 mg,mgTablet · Oral use30 BlisterSAR 60.70Generic · PrescriptionSPIMACOValid
PROVINDA PLUS5,5 mg,mgTablet · Oral use30 BlisterSAR 50.15Generic · PrescriptionSPIMACOValid
Perinam3.5,2.5 mg,mgTablet · Oral use30 BlisterSAR 40.25Generic · PrescriptionAPOTEXValid
Perinam7,5 mg,mgTablet · Oral use30 BlisterSAR 66.40Generic · PrescriptionAPOTEXValid
Perinam14,10 mg,mgTablet · Oral use30 BlisterSAR 88.40Generic · PrescriptionAPOTEXValid
Pratima Duo5,10 mg,mgTablet · Oral use30 BlisterSAR 60.70Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
Pratima Duo10,10 mg,mgTablet · Oral use30 BlisterSAR 85.90Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
Pratima Duo10,5 mg,mgTablet · Oral use30 BlisterSAR 75.35Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
Pratima Duo5,5 mg,mgTablet · Oral use30 BlisterSAR 50.15Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
Prestoprix Plus5,5 mg,mgTablet · Oral use30 BottleSAR 50.15Generic · PrescriptionMed City PharmaValid
Prestoprix Plus5,10 mg,mgTablet · Oral use30 BottleSAR 75.35Generic · PrescriptionMed City PharmaValid
Prestoprix Plus10,10 mg,mgTablet · Oral use30 BottleSAR 85.90Generic · PrescriptionMed City PharmaValid
TENORYL PLUS 10 mg/10 mg TABLET10,10 mg,mgTablet · Oral use30 BottleSAR 95.20Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyValid
TENORYL PLUS 10 mg/5 mg TABLET5,10 mg,mgTablet · Oral use30 BottleSAR 83.45Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyValid
TENORYL PLUS 5 mg/10 mg TABLET10,5 mg,mgTablet · Oral use30 BottleSAR 67.35Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyValid
TENORYL PLUS 5 mg/5 mg TABLET5,5 mg,mgTablet · Oral use30 BottleSAR 55.60Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyValid
VIDONORM 10MG/4MG TABLET10,4 mg,mgTablet · Oral use30 BlisterSAR 79.30NCE · PrescriptionAJA PHARMACEUTICAL INDUSTRIESValid
VIDONORM 10MG/8MG TABLET10,8 mg,mgTablet · Oral use30 BlisterSAR 90.40NCE · PrescriptionAJA PHARMACEUTICAL INDUSTRIESValid
VIDONORM 5MG/4MG TABLET5,4 mg,mgTablet · Oral use30 BlisterSAR 52.80NCE · PrescriptionAJA PHARMACEUTICAL INDUSTRIESValid

1 more — full table

Indications — CHI Daman Drug Formulary

HYPERTENSION

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
PRESTALIAEQ 2.5MG BASE;3.5MG; EQ 5MG BASE;7MG; EQ 10MG BASE;14MGtablet · oralADHERADiscontinued21 Jan 2015

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
APO-PERINDOPRIL/AMLODIPINE024685652.5 MG; 3.5 MGTABLET · ORALAPOTEX INC
APO-PERINDOPRIL/AMLODIPINE024685735 MG; 7 MGTABLET · ORALAPOTEX INC
APO-PERINDOPRIL/AMLODIPINE0246858114 MG; 10 MGTABLET · ORALAPOTEX INC
PMS-PERINDOPRIL-AMLODIPINE025416962.5 MG; 3.5 MGTABLET · ORALPHARMASCIENCE INC
PMS-PERINDOPRIL-AMLODIPINE025417185 MG; 7 MGTABLET · ORALPHARMASCIENCE INC
PMS-PERINDOPRIL-AMLODIPINE0254172610 MG; 14 MGTABLET · ORALPHARMASCIENCE INC
VIACORAM024515303.5 MG; 2.5 MGTABLET · ORALSERVIER CANADA INC
VIACORAM024515497 MG; 5 MGTABLET · ORALSERVIER CANADA INC
VIACORAM0245155710 MG; 14 MGTABLET · ORALSERVIER CANADA INC

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.